LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries

NCT04175197 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 512

Last updated 2019-11-22

No results posted yet for this study

Summary

LEGDEB2 is a Global Registry for the Treatment of Superficial Femoral and/or Popliteal or Below-The-Knee or Iliac Artery Lesions Using the Legflow Drug-Eluting Balloon

Conditions

  • Peripheral Arterial Disease
  • Superficial Femoral Artery Stenosis
  • Iliac Artery Stenosis
  • Arterial Occlusive Diseases
  • Popliteal Artery Stenosis
  • Critical Limb Ischemia

Interventions

DEVICE

Drug Coated Balloon

Legflow Drug Coated Balloon

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-30
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Italy
  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04175197 on ClinicalTrials.gov